Blood test could spot cancer return before scans
NCT ID NCT07453082
Summary
This study aims to learn if a specific substance in the blood, called miRNA371, can tell doctors if testicular cancer is still present or likely to come back. Researchers will observe 100 men with newly diagnosed testicular cancer, collecting their blood and scan results over time. The goal is to see if this blood marker can detect cancer relapse earlier than standard imaging tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione del Piemonte per l'Oncologia
RECRUITINGCandiolo, Turin, 10060, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.